<i>TERT</i> Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients
Telomerase reverse transcriptase gene promoter (<i>TERTp</i>) mutations are recognized as one of the most frequent genetic events in bladder cancer (BC). No studies have focused on the relevance of TERTp mutations in the specific group of tumors treated with Bacillus Calmette−G...
Main Authors: | Rui Batista, Luís Lima, João Vinagre, Vasco Pinto, Joana Lyra, Valdemar Máximo, Lúcio Santos, Paula Soares |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/3/947 |
Similar Items
-
<i>TERT</i> Promoter Mutation Analysis of Whole-Organ Mapping Bladder Cancers
by: Veronika Weyerer, et al.
Published: (2021-02-01) -
Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review
by: Rui Batista, et al.
Published: (2020-01-01) -
Comprehensive Assessment of <i>TERT</i> mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours
by: Ana Pestana, et al.
Published: (2020-07-01) -
Development of Sensitive Droplet Digital PCR Assays for Detecting Urinary <i>TERT</i> Promoter Mutations as Non-Invasive Biomarkers for Detection of Urothelial Cancer
by: Md Ismail Hosen, et al.
Published: (2020-11-01) -
Prospective Analysis of <i>TERT</i> Promoter Mutations in Papillary Thyroid Carcinoma at a Single Institution
by: Yun-Suk Choi, et al.
Published: (2021-05-01)